Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Research Grant, 2022
    Extending Assessment of WATCH-PD Remote Digital Technology

    Study Rationale: Digital tools can provide objective, sensitive, real-world measures of Parkinson’s disease (PD). Better measures could lead to more efficient, patient-centric and timely evaluation of...

  • Research Resources Imaging Program, 2022
    Developing Actionable Machine Learning (AML) Methods for Diagnosing, Monitoring and Treating Parkinson’s Disease

    Study Rationale: In today’s modern age of computational smart health, actionable machine learning (AML) methods automatically and progressively learn how to correctly answer queries about the state of...

  • Novel PET Tracer Development Program, 2022
    Discovery of Novel Radiolabeled Tracers for Imaging Microglia Associated with Neuroinflammation in Parkinson’s disease

    Study Rationale: Parkinson´s disease (PD) is associated with neuroinflammation and the activation of microglia, cells that belong to the brain’s immune system. A protein called Colony stimulating...

  • Research Grant, 2022
    Creation and Testing of a Combined Cognitive Score in Parkinson Disease

    Study Rationale: Many different tests of memory and thinking are given to people with Parkinson’s disease (PD), but it is not clear how to use or combine these test scores to best detect early...

  • Cellular Phenotyping in Human iPSCS from the PPMI Cohort, 2022
    Defining Mechanisms in Different Brain Cells that Drive Progression in Parkinson’s Disease

    Study Rationale: The death of dopamine-producing neurons is the defining feature of Parkinson’s disease (PD), leading to the motor symptoms characteristic of the disorder. Given this obvious...

  • Research Grant, 2022
    Assessing the Aggregation of Alpha-synuclein in the Gastrointestinal Tract

    Study Rationale: A growing body of evidence suggests that Parkinson’s disease (PD) may begin in the stomach or elsewhere along the gastrointestinal (GI) tract before spreading to the brain. If this...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.